Synapse

← npj Antimicrobials and Resistance

Papers in npj Antimicrobials and Resistance

Page 4 · newest first

  1. Citywide metagenomic surveillance of food centres reveals local microbial signatures and antibiotic resistance gene enrichmentnpj Antimicrobials and Resistance · 2025
  2. Enhanced resistance of metal sequestering agents by reconfiguration of the Staphylococcus aureus cell wallnpj Antimicrobials and Resistance · 2025
  3. Human-wildlife ecological interactions shape Escherichia coli population and resistome in two sloth species from Costa Ricanpj Antimicrobials and Resistance · 2025
  4. A systematic review of antimicrobial resistance transmission inferences at the human-livestock interface in Africanpj Antimicrobials and Resistance · 2025
  5. Absence of gut microbiota restoration following meropenem treatment in a systemic infection modelnpj Antimicrobials and Resistance · 2025
  6. Risk of multidrug resistance in Escherichia coli associated with routine antimicrobial prophylaxis on pig farmsnpj Antimicrobials and Resistance · 2025
  7. Beyond breakpoint – reconceptualising AMR as a symptom of planetary stressnpj Antimicrobials and Resistance · 2025
  8. Impact of stereochemical replacement on activity and selectivity of membrane-active antibacterial and antifungal cyclic peptidesnpj Antimicrobials and Resistance · 2025
  9. Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessusnpj Antimicrobials and Resistance · 2025
  10. Current economic and regulatory challenges in developing antibiotics for Gram-negative bacterianpj Antimicrobials and Resistance · 2025
  11. Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antiviralsnpj Antimicrobials and Resistance · 2025
  12. A review of natural products as a source of next-generation drugs against apicomplexan parasitesnpj Antimicrobials and Resistance · 2025
  13. Antibiotic potentiators as a promising strategy for combating antibiotic resistancenpj Antimicrobials and Resistance · 2025
  14. Convergent evolution of antibiotic resistance mechanisms between pyrrolobenzodiazepines and albicidin in multidrug resistant Klebsiella pneumoniaenpj Antimicrobials and Resistance · 2025
  15. Coevolutionary history of predation constrains the evolvability of antibiotic resistance in prey bacterianpj Antimicrobials and Resistance · 2025
  16. Antibiotics re-booted—time to kick back against drug resistancenpj Antimicrobials and Resistance · 2025
  17. Tazobactam selects for multidrug resistancenpj Antimicrobials and Resistance · 2025
  18. Building microbial communities to improve antimicrobial strategiesnpj Antimicrobials and Resistance · 2025
  19. Re-evaluating what makes a phage unsuitable for therapynpj Antimicrobials and Resistance · 2025
  20. Cross resistance emergence to polymyxins in Acinetobacter baumannii exposed in vitro to an antimicrobial peptidenpj Antimicrobials and Resistance · 2025
  21. Cytomegalovirus infection and drug resistance emergence during letermovir salvage therapy in a pediatric SCID patientnpj Antimicrobials and Resistance · 2025
  22. Effect of host microenvironment and bacterial lifestyles on antimicrobial sensitivity and implications for susceptibility testingnpj Antimicrobials and Resistance · 2025
  23. Small-molecule screen in C. elegans identifies benzenesulfonamides as inhibitors of microsporidia sporesnpj Antimicrobials and Resistance · 2025
  24. A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigellanpj Antimicrobials and Resistance · 2025
  25. Reviewing the complexities of bacterial biocide susceptibility and in vitro biocide adaptation methodologiesnpj Antimicrobials and Resistance · 2025
  26. Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillancenpj Antimicrobials and Resistance · 2025
  27. Evolution of an extensively antibiotic resistant sublineage of lineage 1 of GC1 Acinetobacter baumanniinpj Antimicrobials and Resistance · 2025
  28. Genome wide analyses reveal the role of mutator phenotypes in Mycobacterium tuberculosis drug resistance emergencenpj Antimicrobials and Resistance · 2025
  29. Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniaenpj Antimicrobials and Resistance · 2025
  30. Emergence of transferable daptomycin resistance in Gram-positive bacterianpj Antimicrobials and Resistance · 2025
  31. Leveraging the microbiome to combat antibiotic resistant gynecological infectionsnpj Antimicrobials and Resistance · 2025
  32. Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolatesnpj Antimicrobials and Resistance · 2025
  33. Developing the trehalose biosynthesis pathway as an antifungal drug targetnpj Antimicrobials and Resistance · 2025
  34. Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungalsnpj Antimicrobials and Resistance · 2025
  35. Unravelling the linkages between conflict and antimicrobial resistancenpj Antimicrobials and Resistance · 2025
  36. Design, synthesis and optimization of TarO inhibitors as multifunctional antibiotics against Methicillin-resistant Staphylococcus aureusnpj Antimicrobials and Resistance · 2025
  37. Antibacterial compounds against non-growing and intracellular bacterianpj Antimicrobials and Resistance · 2025
  38. Importance of diversity and representation in science: benefits towards strengthening our response to global challengesnpj Antimicrobials and Resistance · 2025
  39. Metabolic state-driven nutrient-based approach to combat bacterial antibiotic resistancenpj Antimicrobials and Resistance · 2025
  40. Evaluating the protective effects of Aurodox in a murine model of Shiga toxin-producing Escherichia colinpj Antimicrobials and Resistance · 2025
  41. Repurposing antimicrobials with ultrasound-triggered nanoscale systems for targeted biofilm drug deliverynpj Antimicrobials and Resistance · 2025
  42. Exploiting social traits for clinical applications in bacteria and virusesnpj Antimicrobials and Resistance · 2025
  43. Integrating socioeconomic deprivation indices and electronic health record data to predict antimicrobial resistancenpj Antimicrobials and Resistance · 2025
  44. How AI can help us beat AMRnpj Antimicrobials and Resistance · 2025
  45. Innovative perspectives on the discovery of small molecule antibioticsnpj Antimicrobials and Resistance · 2025
  46. R-pyocins as targeted antimicrobials against Pseudomonas aeruginosanpj Antimicrobials and Resistance · 2025
  47. Advantages and limitations of large language models for antibiotic prescribing and antimicrobial stewardshipnpj Antimicrobials and Resistance · 2025
  48. Emerging antimicrobial therapies for Gram-negative infections in human clinical usenpj Antimicrobials and Resistance · 2025
  49. Aspergillus fumigatus mitogenomes and their influence on azole-resistant and -susceptible populationsnpj Antimicrobials and Resistance · 2025
  50. Heteroresistance in Enterobacter cloacae complex caused by variation in transient gene amplification eventsnpj Antimicrobials and Resistance · 2025